PAR ASX Paradigm Biopharmaceuticals Ltd

PAR price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

PAR price performance

-9.26%

-27.94%

YTD

-38.75%

PAR price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

PAR details

View company profile

View company website

PAR dividends

PAR Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs Explore Australia companies

Paradigm Biopharmaceuticals Ltd (AU-ASX: PAR)

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

Price: A$0.25

Sector: Healthcare — Biotechnology

PAR ASX Paradigm Biopharmaceuticals Ltd

Paradigm Biopharmaceuticals Ltd share price

PAR price activity

PAR price performance

PAR price fundamentals

Price market cap

PAR details

PAR dividends

More ways to discover

PAR price fundamentals

Price market cap

PAR details